Some medicines can quietly stress your inner ear. The good news: most people can get the treatment they need and keep their hearing healthy—if they plan ahead. This guide shows you how to lower your risk, spot early signs, and work with your care team to protect your ears from ototoxicity.
What is ototoxicity, in plain English?
Ototoxicity means a drug or chemical harms the inner ear (cochlea or vestibular system). It can affect hearing, balance, or both. Symptoms range from subtle to obvious, including:
- New tinnitus (ringing, buzzing, hissing) that wasn’t there before
- “Muffled” sound or trouble hearing high pitches and speech clarity
- Difficulty following conversation in noise
- Fullness or pressure in the ear without infection
- Dizziness, unsteadiness, or a sense that the room is tilting
Not all ototoxic effects are permanent. Some are temporary and dose-related. But others—especially from certain chemotherapy or antibiotic families—can be lasting. That’s why prevention and early monitoring matter.
Common culprits you might encounter
Don’t panic—most people who use these medications do not develop serious hearing problems. Risk depends on dose, duration, personal factors, and combinations with other risks (like loud noise or kidney disease). Never stop a prescribed medicine without talking to your clinician.
Cancer treatments (platinum-based)
- Cisplatin and, to a lesser extent, carboplatin can damage the hair cells that help you hear high frequencies. Risk rises with cumulative dose and in children. Early changes often show up above the range of standard hearing tests—unless you’re monitored.
IV or high-dose antibiotics
- Aminoglycosides (gentamicin, tobramycin, amikacin) are powerful, life-saving antibiotics that can be cochlear and/or vestibular toxic, especially with prolonged courses or high levels.
- Macrolides (especially high-dose IV erythromycin) and vancomycin have been linked to hearing changes in some situations, particularly when combined with other risks.
Pain relievers
- High-dose salicylates (aspirin) can cause reversible tinnitus and temporary hearing reduction. Low-dose aspirin for heart protection is generally not a concern.
- Frequent, long-term use of some NSAIDs (ibuprofen, naproxen) has been associated with a small increased risk of hearing issues in observational studies.
Diuretics (water pills)
- Loop diuretics (furosemide, bumetanide, ethacrynic acid) can cause transient hearing changes, especially when given rapidly IV, at high doses, or alongside aminoglycosides. Kidney disease increases risk.
Antimalarials and related agents
- Quinine, chloroquine, and hydroxychloroquine have rare reports of tinnitus and hearing changes, sometimes reversible. Risk is higher with long-term or high-dose use.
This is not a complete list. New therapies (including some targeted or immunotherapies) may also carry ear-related risks. Ask your care team what’s known about your specific drug.
Your risk isn’t fixed: what raises—or lowers—it
- Higher or cumulative dose, rapid infusion, or prolonged therapy
- Pre-existing hearing loss or tinnitus
- Kidney or liver dysfunction (affects how drugs clear)
- Dehydration or severe illness
- Concurrent use of more than one ototoxic drug
- Noise exposure during treatment (concerts, loud workplaces, power tools)
- Age extremes (newborns/children; older adults)
- Genetic predisposition (for example, MT-RNR1 variants with aminoglycosides)
Flip side: careful dosing, hydration, kidney monitoring, smart noise protection, and audiologic monitoring lower risk.
The prevention playbook you can start today
Before you start an ototoxic medication
- Get a baseline hearing check. Ask for a comprehensive audiologic evaluation that includes high-frequency audiometry (if available) and otoacoustic emissions. Baselines make small changes easier to spot.
- Share your history. Tell your clinician about any hearing loss, tinnitus, balance issues, noise exposure, or family history of drug-related hearing loss.
- Ask about alternatives and dosing. Are there equally effective non-ototoxic options? If not, can dosing or infusion rate reduce risk?
- Discuss monitoring plans. For high-risk drugs (e.g., cisplatin or aminoglycosides), monitoring before each cycle or at least regularly is common. Clarify who orders and reviews tests (oncology, infectious disease, audiology).
- Consider genetics when relevant. If you or a close family member had sudden hearing loss after aminoglycosides, ask about MT-RNR1 testing—especially before newborn or pediatric exposure.
- Plan your noise strategy. Line up earplugs for any loud environments, and aim for quiet recovery time during treatment days.
Pro tip: Add “ear checklist” items to your patient portal or treatment binder so they’re not forgotten amid everything else.
While you’re on treatment
- Monitor symptoms daily. New tinnitus, muffled hearing, or balance changes are signals—don’t ignore them.
- Keep scheduled hearing checks. For high-risk regimens, brief monitoring appointments can catch changes early.
- Protect your ears from noise. Skip the concert, turn down earbuds, and use hearing protection at work and during chores (lawn mowers, saws, blenders).
- Hydrate and track kidney labs. Good hydration and kidney function support safer drug levels.
- Avoid stacking ototoxins when possible. Tell every clinician and pharmacist about current meds to avoid risky combinations.
- Document changes. Jot down dates, symptoms, and possible triggers. Patterns help your team act faster.
If you notice changes
- Contact your care team promptly. Don’t stop a prescribed medication on your own. Early action may include dose adjustments, infusion changes, drug substitution, or scheduling urgent audiology.
- Ask for an expedited hearing test. Comparing to your baseline clarifies whether there’s a shift and how big it is.
- Double down on noise protection. Your ears are vulnerable; give them a quieter soundscape while your team investigates.
Everyday meds: what’s realistic?
It’s easy to worry about common medicines. Here’s a grounded view:
- Low-dose aspirin for heart protection is generally safe for hearing.
- Short courses of NSAIDs at recommended doses are unlikely to cause lasting hearing problems for most people. Chronic, frequent use may carry a small association with hearing changes. If you rely on them often, ask your clinician about alternatives or rotating strategies.
- Acetaminophen doesn’t carry classic ototoxicity, but some population studies link frequent use to hearing concerns. Balance pain control with the lowest effective dose and consider non-drug options when possible.
When in doubt, a quick pharmacist or clinician consult can tailor advice to your health conditions and other meds.
Parents and caregivers: special notes
Newborns and children may receive aminoglycosides or chemotherapy when needed. The stakes are high, and so is the care. You can help by:
- Confirming a hearing screening before discharge and follow-up testing if NICU care or ototoxic medication was used.
- Asking whether dosing is adjusted for age, weight, and kidney function, and whether drug levels are being checked when appropriate.
- Reporting any startle changes, lack of response to sound, or new balance concerns.
You’re not being “difficult.” You’re being a great advocate.
Noise + meds: why your daily soundscape matters
Noise and ototoxic medications can team up in the worst way—what scientists call synergistic risk. That means the combined damage can be greater than either risk alone. During any ototoxic treatment, your ears deserve quiet breaks:
- Aim for a lower daily noise dose: keep earbuds under 60% volume and limit long listening sessions.
- Use hearing protection around machinery, stadiums, and traffic noise.
- Create recovery windows—30–60 minutes of calm after any noisy period.
Your ear-safety checklist
- Know your med’s ear risks and the plan to monitor them.
- Get a baseline hearing test before high-risk treatment; repeat as advised.
- Report new tinnitus, muffled sound, or balance changes within 24–48 hours.
- Protect your ears from loud sound every day, especially during treatment.
- Stay hydrated and keep kidney labs on schedule.
- Avoid stacking ear-risky meds when possible; loop in your pharmacist.
- Keep a simple symptom diary.
When to see an audiologist or ENT
If you’re starting or currently using an ototoxic medication—or you notice new ear symptoms—consider booking with an audiologist for baseline and follow-up testing. An ENT specialist can evaluate medical ear conditions and coordinate with your prescribing team. Early, coordinated care is your best prevention ally.
Bottom line
Most people can successfully balance medical treatment and ear safety. With a solid baseline, smart monitoring, and everyday noise awareness, you give yourself the best chance to finish therapy with your hearing intact. You don’t have to choose between your health and your ears—you can protect both.
Further Reading
- Your Medicine, Your Ears: How to Prevent Drug-Related Hearing Damage (Prevention) - Before You Swallow or Infuse: Outsmart Drug‑Induced Hearing Loss (Prevention) - Medicine And Your Ears: Prevent Drug-Induced Hearing Loss Before It Starts (Prevention) - Medicines Can Be Noisy: Preventing Drug‑Induced Hearing Loss and Tinnitus (Prevention)Frequently Asked Questions
Are ototoxic effects always permanent?
No. Some drug-related hearing changes are temporary and dose-related (for example, high-dose aspirin tinnitus often resolves after the dose is lowered or stopped). Others, such as changes from certain chemotherapy or aminoglycoside antibiotics, can be permanent. Early monitoring and quick communication with your care team improve the odds of minimizing long-term impact.
Can supplements prevent ototoxic hearing loss?
There is no proven supplement that reliably prevents ototoxicity in people. Antioxidants are being studied, but results are mixed and drug-specific. Some supplements can interact with medications. Talk with your clinician before adding anything, and focus on proven strategies: baseline testing, symptom reporting, noise protection, hydration, and appropriate dosing.
Is one dose of an ototoxic medication safe?
Serious ear effects from a single standard dose are uncommon for most medications, but risk depends on the drug type, dose, genetics, and your health. For example, a single high dose of an aminoglycoside in a person with a specific MT-RNR1 variant can cause rapid hearing loss. If you’re concerned, ask your clinician about your personal risk and monitoring.
What if I already have hearing loss or tinnitus?
Tell your care team before starting treatment and get a baseline audiogram. Pre-existing hearing changes can increase your susceptibility and make small shifts harder to notice without testing. An audiologist can help track changes and recommend strategies or devices if needed.